A panelist discusses how ITP diagnosis remains one of exclusion requiring thorough testing to rule out other causes of thrombocytopenia, followed by patient education about autoimmune diseases and ...

Summer and all the running, jumping and playing does not have a corner on the market of finding a bruise on your body when ...

Receiving ganciclovir prophylaxis did not have a benefit on respiratory support-free days vs. placebo in adults with ...

Johnson & Johnson announced today first results from the Phase 3, randomized, double-blind, placebo-controlled AMPLITUDE study evaluating the combination of niraparib and abiraterone acetate plus ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to the Oral Abstract Session: Genitourinary Cancer—Prostate, Testicular, and Penile.

Retifanlimab-dlwr (Zynyz) was granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell ...

A new species of tick, Haemaphysalis longicornis, has been identified in Türkiye for the first time, according to researchers ...

A team led by Rutgers University-New Brunswick engineers has developed a portable device capable of detecting rare genetic ...